Heterozygous Factor V Leiden R506Q Mutation Causing a Life-Threatening Bilateral Pulmonary Embolism in a Young Man With Influenza A Pneumonitis

Abdelkarim Waness, Ashraf Elghul

Abstract


Factor V Leiden (FVL) single R506Q mutation is an inherited familial condition that predisposes to increased risk of thrombophilia. This risk is lower in the heterozygous mutation form compared to the homozygous one. The pathologic clotting might occur at any age group and potentially in various sites of the body vasculature. We present a case of heterozygous form of FVL single R506Q mutation causing life-threatening bilateral pulmonary emboli in a previously healthy young male who suffered severe case of influenza A pneumonitis.




J Hematol. 2014;3(2):54-56
doi: http://dx.doi.org/10.14740/jh127w


Keywords


Factor V Leiden; Single R506Q mutation; Pulmonary emboli; Pleural effusion; Pericardial effusion; Influenza A; Pneumonitis

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Hematology, bimonthly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.